2-naphthaldehyde has been researched along with Leukemia in 1 studies
*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiaradia, LD; Costa, A; Creczinsky-Pasa, TB; Curta, JC; de Moraes, AC; Licínio, MA; Mascarello, A; Nunes, RJ; Pedrini, FS; Santos-Silva, MC; Yunes, RA | 1 |
1 other study(ies) available for 2-naphthaldehyde and Leukemia
| Article | Year |
|---|---|
Induction of apoptosis and cell cycle arrest in L-1210 murine lymphoblastic leukaemia cells by (2E)-3-(2-naphthyl)-1-(3'-methoxy-4'-hydroxy-phenyl)-2-propen-1-one.
Topics: Acetophenones; Aldehydes; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Cycle; Cell Line, Tumor; Chalcones; Leukemia; Leukemia L1210; Lymphocytes; Mice; Naphthalenes; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2010 |